504746 | Idazoxan Hydrochloride - CAS 79944-56-2 - Calbiochem

504746
Price could not be retrieved
Minimum Quantity needs to be mulitiple of
Upon Order Completion More Information
You Saved ()
 
Request Pricing
Limited AvailabilityLimited Availability
Stocked 
Discontinued
Limited Quantities Available
Available
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      View Pricing & Availability
      Click To Print This Page

      Overview

      Replacement Information

      Key Specifications Table

      Empirical FormulaCAS #
      C₁₁H₁₂N₂O₂ • HCl 79944-56-2

      Pricing & Availability

      Catalog NumberAvailability Packaging Qty/Pack Price Quantity
      5.04746.0001
      Retrieving availability...
      Limited AvailabilityLimited Availability
      Stocked 
      Discontinued
      Limited Quantities Available
      Available
        Remaining : Will advise
          Remaining : Will advise
          Will advise
          Contact Customer Service

          Glass bottle 50 mg
          Retrieving price...
          Price could not be retrieved
          Minimum Quantity needs to be mulitiple of
          Upon Order Completion More Information
          You Saved ()
           
          Request Pricing
          Description
          OverviewA non-selective antagonist for α2-adrenoceptors (pKi = 8.01, 7.43, and 7.7 for α2A, α2B, and α2C receptors respectively) and imidazoline receptors. (pKi = 5.90, 7.22 for I1 and I2, receptors respectively). Widely used in studying functions of the nervous systems, such as learning and memory, decision making, reward, attention, addiction, depression, and schizophrenia related to the adrenergic receptors, and blood pressure regulation, pain modulation, and neuroprotection related to the imidazoline receptors.
          Catalogue Number504746
          Brand Family Calbiochem®
          Synonyms2-(1,4-Benzodioxan-2-yl)-2-imidazoline hydrochloride, RX781094, Idazoxa, α₂-Adrenoceptor Antagonist, Idazoxan Hydrochloride
          References
          ReferencesHumpston, S., et al. 2013. J. of Psychopharmacology, 27, 213.
          Dabir, l., 1986. J.Pharmacol. 17, 113.
          Michel, M., et al. 1992. TIPS 13, 369.
          Eglen, R., et al. 1998. TiPS 19, 381.
          Doxey, J., et al. 1984. Br J Pharmacol. 1984. 83, 713.
          Gadie, B., 1984. Br J Pharmacol. 83, 707.
          Product Information
          CAS number79944-56-2
          FormWhite powder
          Hill FormulaC₁₁H₁₂N₂O₂ • HCl
          Chemical formulaC₁₁H₁₂N₂O₂ • HCl
          Structure formula ImageStructure formula Image
          Applications
          Biological Information
          Primary Target→₂-adrenoceptor
          Purity≥98% by TLC
          Physicochemical Information
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          R PhraseR: 25

          Toxic if swallowed.
          S PhraseS: 22-36-45

          Do not breathe dust.
          Wear suitable protective clothing.
          In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible).
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Shipped at Ambient Temperature or with Blue Ice or with Dry Ice
          Toxicity Toxic
          Hazardous Materials Attention: Due to the nature of the Hazardous Materials in this shipment, additional shipping charges may be applied to your order. Certain sizes may be exempt from the additional hazardous materials shipping charges. Please contact your local sales office for more information regarding these charges.
          Storage +15°C to +30°C
          Protect from Light Protect from light
          Do not freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C. Stock solutions are stable for up to 3 months at -20°C.
          Packaging Information
          Transport Information
          Supplemental Information
          Specifications

          Documentation

          SDS

          Title

          Safety Data Sheet (SDS) 

          References

          Reference overview
          Humpston, S., et al. 2013. J. of Psychopharmacology, 27, 213.
          Dabir, l., 1986. J.Pharmacol. 17, 113.
          Michel, M., et al. 1992. TIPS 13, 369.
          Eglen, R., et al. 1998. TiPS 19, 381.
          Doxey, J., et al. 1984. Br J Pharmacol. 1984. 83, 713.
          Gadie, B., 1984. Br J Pharmacol. 83, 707.
          Data Sheet

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision31-May-2013 JSW
          Synonyms2-(1,4-Benzodioxan-2-yl)-2-imidazoline hydrochloride, RX781094, Idazoxa, α₂-Adrenoceptor Antagonist, Idazoxan Hydrochloride
          DescriptionA non-selective antagonist for ?2-adrenoceptors (pKi = 8.01, 7.43, and 7.7 for ?2A, ?2B, and ?2C receptors respectively) and imidazoline receptors. (pKi = 5.90, 7.22 for I1 and I2, receptors respectively). Widely used in studying functions of the nervous systems, such as learning and memory, decision making, reward, attention, addiction, depression, and schizophrenia related to the adrenergic receptors, and blood pressure regulation, pain modulation, and neuroprotection related to the imidazoline receptors.
          FormWhite powder
          CAS number79944-56-2
          Chemical formulaC₁₁H₁₂N₂O₂ • HCl
          Structure formulaStructure formula
          Purity≥98% by TLC
          SolubilityH₂O (50 mg/ml)
          Storage +15°C to +30°C
          Protect from light
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C. Stock solutions are stable for up to 3 months at -20°C.
          Toxicity Toxic
          ReferencesHumpston, S., et al. 2013. J. of Psychopharmacology, 27, 213.
          Dabir, l., 1986. J.Pharmacol. 17, 113.
          Michel, M., et al. 1992. TIPS 13, 369.
          Eglen, R., et al. 1998. TiPS 19, 381.
          Doxey, J., et al. 1984. Br J Pharmacol. 1984. 83, 713.
          Gadie, B., 1984. Br J Pharmacol. 83, 707.